Buy Glenmark Pharma, Cipla, Union Bank of India: CA Rudramurthy BV

CA Rudramurthy BV, Research head at Vachana Investments told CNBC-TV18, "Last week I was very bullish on pharma and now it has been a history. Wockhardt also did very well and again this week I am liking pharma and the theme of pharma should continue for the short-term."

"In Future & Option, especially Glenmark Pharma looks very strong to me and lot of open interest addition is seen with prices moving on the upside and support at levels of Rs 630 and Rs 640 is holding. The stock has definitely seen some accumulation. So, one can look at buying Glenmark for short-term. Look at target of Rs 680 and have a stop loss of Rs 640."

"I have a second buy call on Cipla. This stock has seen lot of accumulation at levels closer to Rs 620, 630 and now we are expecting a breakout. It can immediately move to levels of Rs 655 and above Rs 655 even Rs 675 is possible. Have a stop loss of Rs 630 for this long call," he said.

"I have a buy call on Union Bank of India. This stock after the big up-move is now consolidating, today at least 10 percent open interest is seen and the stock is moving on the positive side and can head towards Rs 195 immediately. Have a stop loss of Rs 174 for this long call," he added.